Lee W Young
Supervisory Patent Examiner (ID: 5212, Phone: (571)272-4549 , Office: P/3902 )
Art Unit(s) | 3103, 3613, 3902, OITP, 2855, 2899, 3727, 3729 |
Total Applications | 106452 |
Issued Applications | 502 |
Pending Applications | 104222 |
Abandoned Applications | 99 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5224676
[patent_doc_number] => 20070253942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Lectin-directed prodrug delivery system'
[patent_app_type] => utility
[patent_app_number] => 11/785261
[patent_app_country] => US
[patent_app_date] => 2007-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23338
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20070253942.pdf
[firstpage_image] =>[orig_patent_app_number] => 11785261
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/785261 | Lectin-directed prodrug delivery system | Apr 15, 2007 | Abandoned |
Array
(
[id] => 4474064
[patent_doc_number] => 07867726
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-11
[patent_title] => 'Compositions comprising a dehalogenase substrate and a fluorescent label and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/786792
[patent_app_country] => US
[patent_app_date] => 2007-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 48
[patent_no_of_words] => 40207
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/867/07867726.pdf
[firstpage_image] =>[orig_patent_app_number] => 11786792
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/786792 | Compositions comprising a dehalogenase substrate and a fluorescent label and methods of use | Apr 11, 2007 | Issued |
Array
(
[id] => 5532982
[patent_doc_number] => 20090232770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'PROCESS OF PRODUCTION OF BACTERIOPHAGE COMPOSITIONS AND METHODS IN PHAGE THERAPY FIELD'
[patent_app_type] => utility
[patent_app_number] => 12/295893
[patent_app_country] => US
[patent_app_date] => 2007-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6436
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232770.pdf
[firstpage_image] =>[orig_patent_app_number] => 12295893
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/295893 | Process of production of bacteriophage compositions and methods in phage therapy field | Apr 2, 2007 | Issued |
Array
(
[id] => 5473020
[patent_doc_number] => 20090246186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'AGENT FOR IMPROVING NERVOUS SYSTEM CELL FUNCTIONS'
[patent_app_type] => utility
[patent_app_number] => 12/295258
[patent_app_country] => US
[patent_app_date] => 2007-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12506
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246186.pdf
[firstpage_image] =>[orig_patent_app_number] => 12295258
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/295258 | AGENT FOR IMPROVING NERVOUS SYSTEM CELL FUNCTIONS | Mar 28, 2007 | Abandoned |
Array
(
[id] => 5085850
[patent_doc_number] => 20070275901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'SYNTHESIS, MODIFICATION AND REDUCTION OF PRIMARY STRUCTURE OF HYPOTENSIVE PEPTIDES PRESENT IN SCORPION VENOM FOR OPTIMIZING THEIR USE AS A HYPOTENSIVE MEDICAMENT'
[patent_app_type] => utility
[patent_app_number] => 11/687785
[patent_app_country] => US
[patent_app_date] => 2007-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3763
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275901.pdf
[firstpage_image] =>[orig_patent_app_number] => 11687785
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/687785 | SYNTHESIS, MODIFICATION AND REDUCTION OF PRIMARY STRUCTURE OF HYPOTENSIVE PEPTIDES PRESENT IN SCORPION VENOM FOR OPTIMIZING THEIR USE AS A HYPOTENSIVE MEDICAMENT | Mar 18, 2007 | Abandoned |
Array
(
[id] => 5010887
[patent_doc_number] => 20070281366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'Target molecule recognition polymer and method for producing the same'
[patent_app_type] => utility
[patent_app_number] => 11/724196
[patent_app_country] => US
[patent_app_date] => 2007-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10548
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20070281366.pdf
[firstpage_image] =>[orig_patent_app_number] => 11724196
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/724196 | Target molecule recognition polymer and method for producing the same | Mar 14, 2007 | Abandoned |
Array
(
[id] => 5188482
[patent_doc_number] => 20070166790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'DERIVATIVES OF MAGAININ AND METHODS OF PRODUCTION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/686190
[patent_app_country] => US
[patent_app_date] => 2007-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10236
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20070166790.pdf
[firstpage_image] =>[orig_patent_app_number] => 11686190
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/686190 | DERIVATIVES OF MAGAININ AND METHODS OF PRODUCTION THEREOF | Mar 13, 2007 | Abandoned |
Array
(
[id] => 5028884
[patent_doc_number] => 20070270331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Modulators of gluconeogenesis'
[patent_app_type] => utility
[patent_app_number] => 11/717426
[patent_app_country] => US
[patent_app_date] => 2007-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10380
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270331.pdf
[firstpage_image] =>[orig_patent_app_number] => 11717426
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/717426 | Modulators of gluconeogenesis | Mar 12, 2007 | Issued |
Array
(
[id] => 4932435
[patent_doc_number] => 20080003210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'NON-HUMAN PRIMATE RECEPTOR TYROSINE KINASES'
[patent_app_type] => utility
[patent_app_number] => 11/684979
[patent_app_country] => US
[patent_app_date] => 2007-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 33664
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20080003210.pdf
[firstpage_image] =>[orig_patent_app_number] => 11684979
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/684979 | NON-HUMAN PRIMATE RECEPTOR TYROSINE KINASES | Mar 11, 2007 | Abandoned |
Array
(
[id] => 5112436
[patent_doc_number] => 20070196351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity'
[patent_app_type] => utility
[patent_app_number] => 11/712684
[patent_app_country] => US
[patent_app_date] => 2007-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15594
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20070196351.pdf
[firstpage_image] =>[orig_patent_app_number] => 11712684
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/712684 | Method of treating a knee meniscus with a cross-linking reagent to increase resistance to tearing or rupturing | Feb 27, 2007 | Issued |
Array
(
[id] => 5348969
[patent_doc_number] => 20090004330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'Glycerol-3-Phosphate Dehydrogenase Gene And Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/280725
[patent_app_country] => US
[patent_app_date] => 2007-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8926
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20090004330.pdf
[firstpage_image] =>[orig_patent_app_number] => 12280725
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/280725 | Glycerol-3-Phosphate Dehydrogenase Gene And Use Thereof | Feb 20, 2007 | Abandoned |
Array
(
[id] => 5005011
[patent_doc_number] => 20070202581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Method for the production of polyhydroxyalkanoic acid'
[patent_app_type] => utility
[patent_app_number] => 11/676928
[patent_app_country] => US
[patent_app_date] => 2007-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9187
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20070202581.pdf
[firstpage_image] =>[orig_patent_app_number] => 11676928
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/676928 | Method for the production of polyhydroxyalkanoic acid | Feb 19, 2007 | Issued |
Array
(
[id] => 7535034
[patent_doc_number] => 08048658
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-01
[patent_title] => 'Method for producing terpenes and MEP-transformed microorganisms therefore'
[patent_app_type] => utility
[patent_app_number] => 12/279300
[patent_app_country] => US
[patent_app_date] => 2007-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11909
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/048/08048658.pdf
[firstpage_image] =>[orig_patent_app_number] => 12279300
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/279300 | Method for producing terpenes and MEP-transformed microorganisms therefore | Feb 12, 2007 | Issued |
Array
(
[id] => 5235978
[patent_doc_number] => 20070128134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'WATER-SOLUBLE KERATIN DERIVATIVE AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/670190
[patent_app_country] => US
[patent_app_date] => 2007-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 5751
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20070128134.pdf
[firstpage_image] =>[orig_patent_app_number] => 11670190
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/670190 | WATER-SOLUBLE KERATIN DERIVATIVE AND USE THEREOF | Jan 31, 2007 | Abandoned |
Array
(
[id] => 5119265
[patent_doc_number] => 20070140979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Method for accelerating the rate of mucociliary clearance'
[patent_app_type] => utility
[patent_app_number] => 11/701347
[patent_app_country] => US
[patent_app_date] => 2007-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 25201
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0140/20070140979.pdf
[firstpage_image] =>[orig_patent_app_number] => 11701347
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/701347 | Method for accelerating the rate of mucociliary clearance | Jan 30, 2007 | Abandoned |
Array
(
[id] => 5076335
[patent_doc_number] => 20070119559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'Enzymatic Treatment of Paper Making Pulps'
[patent_app_type] => utility
[patent_app_number] => 11/669438
[patent_app_country] => US
[patent_app_date] => 2007-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7602
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20070119559.pdf
[firstpage_image] =>[orig_patent_app_number] => 11669438
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/669438 | Enzymatic Treatment of Paper Making Pulps | Jan 30, 2007 | Abandoned |
Array
(
[id] => 24347
[patent_doc_number] => 07795405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-14
[patent_title] => 'Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis'
[patent_app_type] => utility
[patent_app_number] => 11/668319
[patent_app_country] => US
[patent_app_date] => 2007-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5960
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 279
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/795/07795405.pdf
[firstpage_image] =>[orig_patent_app_number] => 11668319
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/668319 | Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis | Jan 28, 2007 | Issued |
Array
(
[id] => 5080476
[patent_doc_number] => 20070123700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'Processes for removing cells and cell debris from tissue and tissue constructs used in transplantation and tissue reconstruction'
[patent_app_type] => utility
[patent_app_number] => 11/698818
[patent_app_country] => US
[patent_app_date] => 2007-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8994
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20070123700.pdf
[firstpage_image] =>[orig_patent_app_number] => 11698818
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/698818 | Processes for removing cells and cell debris from tissue and tissue constructs used in transplantation and tissue reconstruction | Jan 25, 2007 | Abandoned |
Array
(
[id] => 5284422
[patent_doc_number] => 20090098097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'COMPOSITION FOR NORMALIZING BLOOD PRESSURE'
[patent_app_type] => utility
[patent_app_number] => 12/162091
[patent_app_country] => US
[patent_app_date] => 2007-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6416
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20090098097.pdf
[firstpage_image] =>[orig_patent_app_number] => 12162091
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/162091 | COMPOSITION FOR NORMALIZING BLOOD PRESSURE | Jan 24, 2007 | Abandoned |
Array
(
[id] => 4909646
[patent_doc_number] => 20080020412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'Aurora expression constructs'
[patent_app_type] => utility
[patent_app_number] => 11/649725
[patent_app_country] => US
[patent_app_date] => 2007-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10349
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20080020412.pdf
[firstpage_image] =>[orig_patent_app_number] => 11649725
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/649725 | Aurora expression constructs | Jan 2, 2007 | Abandoned |